<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03013647</url>
  </required_header>
  <id_info>
    <org_study_id>1.788.362</org_study_id>
    <nct_id>NCT03013647</nct_id>
  </id_info>
  <brief_title>Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization</brief_title>
  <official_title>Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization - Clinical and Histopathological Analysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo General Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Twenty patients with multiple actinic keratosis on the face will be enrolled in the study and
      will be treated with Daylight Photodynamic therapy.

      Before and after skin biopsies will be performed, for histological and immunohistochemical
      analysis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty patients with multiple thin actinic keratosis (AK) on the face will be included in the
      study. They will be informed of the procedure in detail and sign a consent form.

      Digital photographs will be done in a standardized way. Prior to treatment, all patients will
      undergo 2 skin biopsies under local anesthesia and with a 2 mm punch biopsy. One biopsy will
      be done over an AK lesion and the other in an area with no apparent AK (field cancerization).

      The patients will be treated with Daylight Photodynamic Therapy, following these steps:

        1. mild curettage of the AK lesions

        2. application of a chemical sunscreen with sun protection factor (SPF) 30

        3. application of methyl Aminolevulinate cream (Metvix R, Galderma Laboratories)

        4. exposition to daylight, for 120 minutes

        5. cleaning of the face

      Three months after treatment, two new skin biopsies will be collected, 1cm away from the
      initial biopsies. On the same date, new photographs will be made following the same standards
      as pre-treatment photographs.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">April 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical improvement</measure>
    <time_frame>3 months after treatment</time_frame>
    <description>Counting of Actinic keratosis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Histological changes</measure>
    <time_frame>3 months after treatment</time_frame>
    <description>Histopathologic analysis in skin biopsies</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>immunochemistry changes</measure>
    <time_frame>3 months after treatment</time_frame>
    <description>immunochemistry analysis in skin biopsies</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Actinic Keratosis</condition>
  <arm_group>
    <arm_group_label>Actinic Keratosis</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Twenty patients with multiple thin AK on the face will be treated with Daylight Photodynamic Therapy with methyl aminolevulinate Skin biopsies before and after treatment will be performed in an AK lesion and in a field cancerization area.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Methyl Aminolevulinate</intervention_name>
    <description>Patients will be treated with Daylight Photodynamic therapy, following these steps:
mild curettage of the AK lesions
application of a chemical sunscreen SPF 30
application of methyl aminolevulinate cream (Metvix R, Galderma Laboratories)
exposition to daylight, for 120 minutes
cleaning of the face</description>
    <arm_group_label>Actinic Keratosis</arm_group_label>
    <other_name>Metvix</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        -multiple (at least five) actinic keratosis on the face, grades I and II

        Exclusion Criteria:

          -  phototypes IV, V and VI

          -  patients treated for actinic keratosis up to 6 months before

          -  history of allergy to methyl aminolevulinate

          -  history of photoallergy

          -  pregnancy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cyro Festa, md</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital das Clinicas da USP</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Beni Grinblat, md</last_name>
    <phone>551138827070</phone>
    <email>bgrinblat@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Luis Torezan, md</last_name>
    <email>torezanluis@uol.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital das Clinicas</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Beni Grinblat, md</last_name>
      <phone>551138827070</phone>
      <email>bgrinblat@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Luis torezan, md</last_name>
      <email>torezanluis@uol.com.br</email>
    </contact_backup>
    <investigator>
      <last_name>Beni Grinblat, md</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luis Torezan, md</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Fargnoli MC, Piccioni A, Neri L, Tambone S, Pellegrini C, Peris K. Long-term efficacy and safety of daylight photodynamic therapy with methyl amninolevulinate for actinic keratosis of the face and scalp. Eur J Dermatol. 2017 Feb 1;27(1):89-91. doi: 10.1684/ejd.2016.2882.</citation>
    <PMID>27748261</PMID>
  </reference>
  <reference>
    <citation>Grinblat B, Galimberti G, Pantoja G, Sanclemente G, Lopez M, Alcala D, Torezan L, Kerob D, Pascual T, Chouela E. Feasibility of daylight-mediated photodynamic therapy for actinic keratosis throughout the year in Central and South America: a meteorological study. Int J Dermatol. 2016 Sep;55(9):e488-93. doi: 10.1111/ijd.13256. Epub 2016 Apr 7.</citation>
    <PMID>27061814</PMID>
  </reference>
  <reference>
    <citation>Philipp-Dormston WG, Sanclemente G, Torezan L, Tretti Clementoni M, Le Pillouer-Prost A, Cartier H, Szeimies RM, Bjerring P. Daylight photodynamic therapy with MAL cream for large-scale photodamaged skin based on the concept of 'actinic field damage': recommendations of an international expert group. J Eur Acad Dermatol Venereol. 2016 Jan;30(1):8-15. doi: 10.1111/jdv.13327. Epub 2015 Nov 9. Review.</citation>
    <PMID>26552049</PMID>
  </reference>
  <reference>
    <citation>Grinblat B, Galimberti G, Chouela E, Sanclemente G, Lopez M, Alcala D, Torezan L, Pantoja G. Daylight-mediated photodynamic therapy for actinic damage in Latin America: consensus recommendations. Photodermatol Photoimmunol Photomed. 2016 Mar;32(2):81-7. doi: 10.1111/phpp.12221. Epub 2015 Dec 9. Review.</citation>
    <PMID>26541910</PMID>
  </reference>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2016</study_first_submitted>
  <study_first_submitted_qc>January 5, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 6, 2017</study_first_posted>
  <last_update_submitted>January 5, 2017</last_update_submitted>
  <last_update_submitted_qc>January 5, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 6, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo General Hospital</investigator_affiliation>
    <investigator_full_name>BENI MOREINAS GRINBLAT</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>actinic keratosis</keyword>
  <keyword>field cancerization</keyword>
  <keyword>photodynamic therapy</keyword>
  <keyword>daylight photodynamic therapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratosis</mesh_term>
    <mesh_term>Keratosis, Actinic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aminolevulinic Acid</mesh_term>
    <mesh_term>Methyl 5-aminolevulinate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

